A Vaccine Boost

When a bank’s earnings cause the stock to pop more than 15%, then something definitely went right. At least that is what appears to have happened at SoFi this most recent quarter thanks to an earnings beat and raised guidance. Matt, Lou, and Tyler look at the highlights of the ea ...  Show more

Anthropic's highly anticipated IPO filing reveals explosive growth, surprisingly strong financials, and nearly $500 billion in future AI computing commitments. Meanwhile, Meta looks to raise $95 billion as AI infrastructure companies face mounting financing pressures. Plus, Veriz ...  Show more

It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ...

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ...

The morning after the best day for both the S&P 500 and Nasdaq since March, Carl Quintanilla, Jim Cramer and David Faber led off the show with news out of Pfizer and BioNTech: Data shows their COVID-19 vaccine neutralized the omicron variant with three shots. The anchors discusse ...  Show more